INFORMATION FOR
News
Meet Ralph Brooks, who helps identify how to optimally deliver lifesaving treatments to individuals who need them.
A new study demonstrates how public health strategies aimed at improving HIV treatment outcomes can be used to better care for patients with another viral infection, hepatitis C. Hepatitis C is a deadly blood-borne disease that causes liver inflammation and scarring.
A team of researchers across Yale School of Medicine and the University of Texas Health Science Center at San Antonio has published a set of papers on innovations in patient care for those diagnosed with hepatitis C who also are living with HIV.
On May 24, 2023, 65 staff members from the Department of Internal Medicine were recognized for service anniversaries, ranging from five to 40 years.
A new clinical trial, the ‘Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION)’ initiative, is currently recruiting participants.